Concepedia

Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease

Pierre‐Antoine Juge, Keigo Hayashi, Gregory C McDermott, Kathleen M.M. Vanni, Emily Kowalski, Grace Qian, Katarina J Bade, Alene Saavedra, Philippe Dieudé, Paul F. Dellaripa,

Seminars in Arthritis and Rheumatism · 2023 · 41 citations · 30 references

DOIFull text

Open access

Concepts

References

30

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text

, , +13

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

, , +13

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +11

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

, , +8

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study

Tim Bongartz, Carlotta Nannini, Yimy F. Medina et al. · Arthritis & Rheumatism · 2010 · 860 citations

, , +14